Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Fox Run Management L.L.C.

Fox Run Management L.L.C. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 294.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,918 shares of the medical equipment provider's stock after purchasing an additional 1,432 shares during the quarter. Fox Run Management L.L.C.'s holdings in Intuitive Surgical were worth $1,001,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Atala Financial Inc purchased a new stake in Intuitive Surgical during the 4th quarter worth about $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $31,000. Finally, Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Remove Ads

Intuitive Surgical Stock Performance

ISRG stock traded down $1.13 during midday trading on Thursday, hitting $507.90. 1,472,266 shares of the stock were exchanged, compared to its average volume of 1,463,857. The stock has a market cap of $180.90 billion, a price-to-earnings ratio of 79.24, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock's 50-day moving average price is $559.82 and its 200-day moving average price is $532.42.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on ISRG. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Bernstein Bank boosted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday, January 27th. Raymond James boosted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Finally, Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research note on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.